Cyteir Therapeutics Eulerpool News

Cyteir Therapeutics Eulerpool News

Cyteir Therapeutics Aktie News

Cyteir Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Cyteir Therapeutics News stellen wir hier zusammen.

• 7. März ·

  Yahoo
  Cyteir Announces Timeline for Voluntarily Delisting from Nasdaq
• 7. März ·

  Thefly.com
  Cyteir Therapeutics announces timeline for voluntarily delisting from Nasdaq
• 20. Februar ·

  Business Wire
  Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
• 5. Januar ·

  Thefly.com
  Cyteir Therapeutics downgraded to Underperform at BofA, coverage terminated
• 1. November ·

  Fintel
  Cyteir Therapeutics (CYT) Price Target Increased by 20.00% to 3.06
• 12. Oktober ·

  Yahoo
  Ongoing Results From a Dose Expansion Cohort of CYT-0851 in Combination With Capecitabine in Advanced Platinum-Resistant Ovarian Cancer Show Promising Clinical Activity and Generally Well Tolerated Safety Profile
• 12. Oktober ·

  Thefly.com
  Cyteir: Cohort of CYT-0851 in combo for ovarian cancer well tolerated
• 18. September ·

  SeekingAlpha
  Cyteir: Although The Company Is Winding Down, The Lead Asset Had Promise
• 11. Juli ·

  Fintel
  Fmr Now Owns 2.33% of Cyteir Therapeutics (CYT)
• 6. Juli ·

  Fintel
  Cyteir Therapeutics (CYT) Price Target Increased by 7.14% to 2.55